NASDAQ:VTGN
VistaGen Therapeutics Inc Stock News
$4.75
+0.0500 (+1.06%)
At Close: Apr 26, 2024
8 Penny Stocks to Watch Right Now As June Comes to an End
06:40pm, Sunday, 27'th Jun 2021
Which penny stocks are investors watching as June comes to an end? The post 8 Penny Stocks to Watch Right Now As June Comes to an End appeared first on Penny Stocks to Buy, Picks, News and Information
SOUTH SAN FRANCISCO, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc . (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the p
Sage Stock Declines on Late-Stage Depression Study Data
11:17am, Wednesday, 16'th Jun 2021
Sage is developing zuranolone as a potential treatment for major depression disorder in late-stage studies.
VistaGen Therapeutics Set to Join the Russell 2000® Index
08:00am, Wednesday, 16'th Jun 2021
SOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc . (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of
7 A-Rated Biotech Stocks to Buy Now
11:06am, Tuesday, 15'th Jun 2021
Investors in search of long-term growth are increasingly choosing biotech stocks like BNTX stock and MRNA stock for their portfolios. The post 7 A-Rated Biotech Stocks to Buy Now appeared first on Inv
5 Buy-Rated Stocks Trading Below $10 With Outstanding Upside Potential
06:05am, Saturday, 12'th Jun 2021
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
VistaGen Kick Starts Late-Stage Social Anxiety Disorder Study with PH94B
09:28am, Wednesday, 26'th May 2021
VistaGen Therapeutics Inc (NASDAQ: VTGN) has initiated its PALISADE Phase 3 study to evaluate PH94B for the acute treatment of Social Anxiety Disorder (SAD). PH94B is an odorless, rapid-onset, invest
VTGN Stock Price: 9.3% Increase Explanation
10:35pm, Sunday, 23'rd May 2021
The stock price of Vistagen Therapeutics Inc (NASDAQ: VTGN) increased by 9.3% on Friday, May 21. This is why it happened.
5 Penny Stocks Analysts Say To Buy With Targets Up To 219% Right Now
07:45pm, Sunday, 23'rd May 2021
Analysts say these are penny stocks to buy right now & have bullish targets to back it up. The post 5 Penny Stocks Analysts Say To Buy With Targets Up To 219% Right Now appeared first on Penny Stocks
Vistagen Therapeutics (VTGN) Stock: Over 14% Increase Pre-Market Explanation
06:13am, Thursday, 20'th May 2021
The stock price of Vistagen Therapeutics Inc (NASDAQ: VTGN) increased by over 14% pre-market. This is why it happened.
Hot Penny Stocks to Watch; Is it Time to Buy The Biotech Dip?
11:40am, Thursday, 29'th Apr 2021
Penny stocks present opportunities to buy the dip often; is that the case with these biotech stocks? The post Hot Penny Stocks to Watch; Is it Time to Buy The Biotech Dip?
Penny Stocks Watchlists and How to Make One
04:48pm, Wednesday, 28'th Apr 2021
Penny stock watchlists? Why they're not as complicated as they seem The post Penny Stocks Watchlists and How to Make One appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock
Novel Anxiety and Depression Approach by VistaGen Therapeutics
09:33am, Tuesday, 27'th Apr 2021
The COVID-19 pandemic has exacerbated mental health issues and is triggering new conditions for people already suffering from mental illnesses and substance abuse. Social anxiety disorder (SAD) is o
VistaGen: Phase 2 Success In Anxiety Disorder, Phase 3 To Begin
08:00am, Sunday, 25'th Apr 2021
VistaGen has had a tumultuous history, but recent trials have seen success. They may start phase 3 trials for PH94B in May.
VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March
07:46am, Tuesday, 16'th Mar 2021
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medici